SCHEMBL5524902

SCHEMBL5524902

CC(C)(C)NC(=O)c1cc(-c2ccc(NC(=O)OC(C)(C)C)cn2)n(-c2cccnc2)n1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAMPT P43490 2/20 0.48
CNR1 P21554 2/20 0.46
CNR2 P34972 2/20 0.46
BCL2 P10415 3/20 0.39
MARS1 P56192 2/20 0.37
BECN1 Q14457 1/20 0.36
DHODH Q02127 1/20 0.36
MAPK13 O15264 1/20 0.36
MAPK12 P53778 1/20 0.36
MAPK11 Q15759 1/20 0.36
MAPK14 Q16539 1/20 0.36
GPR119 Q8TDV5 1/20 0.36
CYP2D6 P10635 1/20 0.35
PORCN Q9H237 1/20 0.35
SLC16A3 O15427 1/20 0.35
SLC16A1 P53985 1/20 0.35
CYP1A2 P05177 1/20 0.35
HTR2C P28335 1/20 0.35
HTR2B P41595 1/20 0.35
EPHX2 P34913 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5519799 0.91 CNR1 (0.49) NAMPTCNR1CNR2BCL2MARS1
SCHEMBL4934933 0.90 NAMPT (0.48) NAMPTCNR1CNR2BCL2MARS1
SCHEMBL5526416 0.88 CNR1 (0.46) NAMPTCNR1CNR2BCL2MARS1
SCHEMBL5518699 0.87 NAMPT (0.42) NAMPTCNR1CNR2BCL2MAPK14
SCHEMBL4929002 0.86 KMT2A (0.46) NAMPTCNR1CNR2BCL2
SCHEMBL5522940 0.85 NAMPT (0.47) NAMPTCNR1CNR2MARS1DHODH
SCHEMBL5526269 0.84 CNR1 (0.51) CNR1CNR2MARS1
SCHEMBL5522084 0.83 CNR1 (0.52) CNR1CNR2MARS1DHODHMAPK13
SCHEMBL5522031 0.83 CNR1 (0.52) CNR1CNR2MARS1MAPK13MAPK12
SCHEMBL5522538 0.83 CNR1 (0.49) CNR1CNR2MARS1DHODHSLC16A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070219210-A1 Amidopyrazole Derivative DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2007-09-20 US disclosed
US-20070219210-A1 Amidopyrazole Derivative DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2007-09-20 US disclosed
US-20070219210-A1 Amidopyrazole Derivative DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2007-09-20 US disclosed
EP-1698626-A1 AMIDOPYRAZOLE DERIVATIVE DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2006-09-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070219210-A1 Amidopyrazole Derivative PTGER1, PTGS1, PTGER2 NAMPT 2905/4885CNR1 76/4885CNR2 43/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.